1. Home
  2. TIL vs AISP Comparison

TIL vs AISP Comparison

Compare TIL & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • AISP
  • Stock Information
  • Founded
  • TIL 2018
  • AISP 2006
  • Country
  • TIL United States
  • AISP United States
  • Employees
  • TIL N/A
  • AISP N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • AISP Blank Checks
  • Sector
  • TIL Health Care
  • AISP Finance
  • Exchange
  • TIL Nasdaq
  • AISP Nasdaq
  • Market Cap
  • TIL 171.7M
  • AISP 138.3M
  • IPO Year
  • TIL 2021
  • AISP N/A
  • Fundamental
  • Price
  • TIL $22.12
  • AISP $5.00
  • Analyst Decision
  • TIL Strong Buy
  • AISP Strong Buy
  • Analyst Count
  • TIL 4
  • AISP 2
  • Target Price
  • TIL $114.00
  • AISP $9.00
  • AVG Volume (30 Days)
  • TIL 83.9K
  • AISP 2.1M
  • Earning Date
  • TIL 03-20-2025
  • AISP 03-31-2025
  • Dividend Yield
  • TIL N/A
  • AISP N/A
  • EPS Growth
  • TIL N/A
  • AISP N/A
  • EPS
  • TIL N/A
  • AISP 0.73
  • Revenue
  • TIL N/A
  • AISP $24,050,308.00
  • Revenue This Year
  • TIL N/A
  • AISP $96.54
  • Revenue Next Year
  • TIL N/A
  • AISP $30.59
  • P/E Ratio
  • TIL N/A
  • AISP $6.82
  • Revenue Growth
  • TIL N/A
  • AISP 148.46
  • 52 Week Low
  • TIL $9.62
  • AISP $1.43
  • 52 Week High
  • TIL $92.00
  • AISP $14.32
  • Technical
  • Relative Strength Index (RSI)
  • TIL 48.67
  • AISP 47.83
  • Support Level
  • TIL $19.00
  • AISP $4.80
  • Resistance Level
  • TIL $25.80
  • AISP $6.86
  • Average True Range (ATR)
  • TIL 2.19
  • AISP 0.63
  • MACD
  • TIL 0.22
  • AISP -0.04
  • Stochastic Oscillator
  • TIL 45.88
  • AISP 36.52

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permission-based architecture.

Share on Social Networks: